EMERGING ANTIMICROBIALS AND DIAGNOSTICS in AMR: 26/27 NOV 2024

Search for:

Home » _News » Smart Innovations » Page 15

AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.

Researchers develop software to find drug-resistant bacteria

Chess with bacteria

New technique in which drugs make bacteria glow could help fight antibiotic resistance

Current state of the art in rapid diagnostics for antimicrobial resistance

CARB-X FUNDS ELIGO BIOSCIENCE TO DEVELOP CRISPR-BASED THERAPEUTICS DERIVED FROM BACTERIOPHAGES TO KILL SUPERBUGS AND PREVENT DEADLY INFECTIONS IN TRANSPLANT PATIENTS

An Analysis of Antibacterial Drug Development Trends in the US, 1980 – 2019

Major boost in global fight against antimicrobial resistance as AMR Centre receives share of Strength in Places Fund award

CARB-X FUNDS UNIVERSITY OF QUEENSLAND TO ACCELERATE THE DEVELOPMENT OF A NEW CLASS OF LAST-RESORT ANTIBIOTICS TO TREAT DEADLY SUPERBUG INFECTIONS

WAAW from 18-24 November, 2020

CARB-X EXPANDS AWARDS TO AMICROBE BY $4.6M TO ACCELERATE DEVELOPMENT OF TWO DISTINCT AMICIDIN-Β TOPICAL ANTIMICROBIAL PRODUCTS

AMR, the unstoppable assassin

Antimicrobial Peptides: The future weapon in fight against antibiotic resistance

Innovative Metagenomics Study Maps Out Antibiotic Resistance Genes from Hospital Environment Microbiomes

CARB-X FUNDS MODULE INNOVATIONS TO DEVELOP A SIMPLE TEST TO DIAGNOSE URINARY TRACT INFECTIONS (UTI) AND IDENTIFY SUPERBUGS CAUSING THE INFECTION WITHIN 2 HOURS

World-first scheme underway to tackle AMR and protect UK patients

Developing antimicrobial stewardship programs using AI models to ensure optimal selection of antibiotics

Antibiotics Special Issue: Challenges and Opportunities in Antibiotic Discovery and Development

A View from the Wellcome Trust Drug-Resistant Infections Priority Programme: Creating a Sustainable Research and Development Ecosystem to Meet the Global Need for Antibiotics

How to Stimulate and Facilitate Early Stage Antibiotic Discovery

NIAID’s Comprehensive Support Mechanisms for Antibiotic Development

The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development

On the Road to Discovering Urgently Needed Antibiotics: So Close Yet So Far Away

The Antibacterial Research and Development Pipeline Needs Urgent Solutions

Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities

The REPAIR Impact Fund launches global call for new investment proposals to fight AMR

FDA Approves Merck’s RECARBRIO™ for the Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

A financial model for an impact investment fund for the development of antibacterial treatments and diagnostics

A financial model for an impact investment fund for the development of antibacterial treatments and diagnostics

Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984–2018: an evaluation of Food and Drug Administration flexibilities

FDA Accepts Shionogi’s Supplemental New Drug Application with Priority Review for FETROJA® (cefiderocol) for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

CARB-X FUNDS MICROBION TO DEVELOP INHALED DRUG TO TREAT CYSTIC FIBROSIS-RELATED LUNG INFECTIONS

CARB-X FUNDS FACILE THERAPEUTICS TO DEVELOP A NEW TREATMENT TO PREVENT RECURRING C. DIFFICILE BACTERIAL INFECTIONS

Why a UK clinical trial could lead the way for antimicrobial resistance efforts

The effects of gamification on antimicrobial resistance knowledge and its relationship to dentistry in Saudi Arabia: a randomized controlled trial

How AI Could Revolutionise The Fight Against Antimicrobial Resistance

Bioactive Phytocompounds to Fight Against Antimicrobial Resistance

What If We Could Fight Antibiotic Resistance With Probiotics?

Begin with the end in mind: designing synthetic antibiotics with a universal mechanism of action

SMART researchers uncover new anti-phage defence mechanisms in bacteria

A computerized decision support system (CDSS) for antibiotic prescription in primary care—Antibioclic: implementation, adoption and sustainable use in the era of extended antimicrobial resistance

Fecal Transplantation Improves Outcomes in Patients with Multi-Drug Resistant Organisms

New Insight into Bacterial Structure to Help Fight Against Superbugs

WHO 2020 preclinical antibacterial pipeline data call open

Venatorx Pharmaceuticals and GARDP partner to develop new antibiotic for hospital acquired infections with limited treatment options

Peptide weakens superbugs to make old antibiotics effective again

Childhood vaccines and antibiotic use in low- and middle-income countries

New drug formulation could treat Candida infections

Biopharma Start-Up Bugworks Raises $7.5 Mln In Fresh Financing

DA Grants Breakthrough Device Designation to DNAe’s Sequencing Diagnostic

Tracking the Global Pipeline of Antibiotics in Development, April 2020

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed